SCHEMBL21177349

SCHEMBL21177349

Cc1cc(Br)cc(C(=O)NCCO)c1Cl

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ HPGD P15428 3/20 0.46
▸ CYP1A2 P05177 2/20 0.45
▸ CA12 O43570 2/20 0.43
▸ CA1 P00915 2/20 0.43
▸ CA2 P00918 2/20 0.43
▸ CA3 P07451 2/20 0.43
▸ CA4 P22748 2/20 0.43
▸ CA6 P23280 2/20 0.43
▸ CA5A P35218 2/20 0.43
▸ CA7 P43166 2/20 0.43
▸ CA9 Q16790 2/20 0.43
▸ CA13 Q8N1Q1 2/20 0.43
▸ CA14 Q9ULX7 2/20 0.43
▸ CA5B Q9Y2D0 2/20 0.43
▸ POLB P06746 3/20 0.42
▸ HTT P42858 1/20 0.42
▸ ALDH1A1 P00352 4/20 0.41
▸ KDM4E B2RXH2 3/20 0.41
▸ MAPT P10636 3/20 0.40
▸ CASP1 P29466 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21177406 0.91 CDK1 (0.49) HPGDCYP1A2CA12CA1CA2
SCHEMBL2800276 0.78 SMN1; SMN2 (0.50) HPGDCYP1A2CA12CA1CA2
SCHEMBL28472945 0.77 ALDH1A1 (0.48) HPGDCYP1A2CA12CA1CA2
SCHEMBL11972812 0.73 AKR1C3 (0.47) ALDH1A1KDM4EMAPTPTGS2HSD17B10
SCHEMBL21177628 0.71 LMNA (0.40) HPGDCYP1A2POLBALDH1A1KDM4E
SCHEMBL8980880 0.70 KDM4E (0.69) HPGDCYP1A2CA12CA1CA2
SCHEMBL9665990 0.70 ESRRG (0.60) HPGDPOLBHTTALDH1A1KDM4E
SCHEMBL24270107 0.70 CYP1A2 (0.62) HPGDCYP1A2HTTALDH1A1KDM4E
SCHEMBL6650108 0.70 L3MBTL1 (0.48) HPGDCYP1A2CA12CA1CA2
SCHEMBL29548598 0.70 CYP1A2 (0.62) HPGDCYP1A2HTTALDH1A1KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3740489-A1 PI4KIIIBETA INHIBITORS GlaxoSmithKline Intellectual Property Development Limited (GB) 2020-11-25 — — EP disclosed
WO-2019141694-A1 PI4KIIIBETA INHIBITORS GLAXOSMITHKLINE INTELLECTUAL PROPERTY DEVELOPMENT LIMITED (GB) 2019-07-25 — — WO disclosed
Send feedback